Triple Insulin Therapy Helps Diabetics

Published Online: Wednesday, September 1, 2004

Patients with type 2 diabetes show improved glucose control using insulin and 2 types of insulin-sensitizing drugs (metformin and troglitazone), without triggering weight gain. The study, which involved 28 participants, compared dual therapy with triple therapy. The results of the study found that control of glucose levels improved with dual therapy and further improved after 4 months of triple therapy. Also, triple drug therapy was linked with a major decrease in total daily insulin dose, reported the authors in Diabetes Care (July 2004).

For the study, the participants initially assigned to take insulin and troglitazone gained an average of 10 pounds after 4 months, but no additional weight was gained when metformin was added. The researchers noted, however, that the participants who took insulin and metformin did not gain weight during the initial 4 months or during the 4 months after troglitazone was added.



Latest Articles
This weekly video program highlights the latest in pharmacy news, product news, and more.
Propranolol is red, digoxin is blue. Your pharmacist’s heart may skip a beat if they get a valentine from you.
Health-system pharmacists can play a critical role in managing drug shortages to prevent medical errors and adverse events.
The White House is asking Congress for more than $1.8 billion in emergency funding to combat the Zika virus, which is creeping into the United States and ravaging some foreign countries.
Latest Issues
$auto_registration$
VSEO N/A